Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse E-Cadherin Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 24 publications
Supplier: R&D Systems AF648
This item is not returnable.
View return policy
Description
E-Cadherin Polyclonal specifically detects E-Cadherin in Human, Mouse samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-ready, Dual RNAscope ISH-IHC.Specifications
E-Cadherin | |
Polyclonal | |
Unconjugated | |
P12830 | |
CDH1 | |
Mouse myeloma cell line NS0-derived recombinant human E-Cadherin Asp155-Ile707 Accession # P12830 | |
100 μg | |
Primary | |
Detects human E-Cadherin in direct ELISAs and Western blots. | |
Human, Mouse | |
IgG |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF, In Situ Hybridization (ISH) | |
LYOPH | |
Western Blot 0.5 ug/mL, Simple Western 5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 0.3-15 ug/mL, Immunocytochemistry 5-15 ug/mL, CyTOF-ready, Dual RNAscope ISH-IHC 0.3-15 ug/mL | |
Arc-1, CAD1, cadherin 1, E-cadherin (epithelial), cadherin 1, type 1, E-cadherin (epithelial), cadherin-1, calcium-dependent adhesion protein, epithelial, CAM 120/80, CD324, CD324 antigen, CDH1, CDHE, cell-CAM 120/80, Cell-CAM120/80, ECAD, E-cadherin, ECadherin, Epithelial cadherin, LCAM, L-CAM, UVOE-Cadherin, uvomorulin | |
Goat | |
Affinity Purified | |
RUO | |
999 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction